Condensed Statements Of Operations (USD $) Share data in Thousands, except Per Share data, unless otherwise specified	12 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2011
Condensed Statements Of Operations [Abstract]
SALES	$ 16,590,000	$ 17,027,000	$ 12,571,000
COST OF GOODS SOLD	8,407,000	8,645,000	6,030,000
Gross profit	8,183,000	8,382,000	6,541,000
COSTS AND EXPENSES
Sales and marketing	7,719,000	7,027,000	5,197,000
General and administrative	2,515,000	3,393,000	2,808,000
Research and development	2,269,000	2,189,000	2,238,000
Change in value of acquisition consideration	(447,000)	(172,000)
Gain on demutualization	(321,000)
Medical device tax	106,000
Amortization of identifiable intangible assets	104,000	90,000	24,000
Impairment of identifiable intangible assets	160,000
Total costs and expenses	12,105,000	12,527,000	10,267,000
OPERATING LOSS	(3,922,000)	(4,145,000)	(3,726,000)
INTEREST INCOME/(EXPENSE)	(555,000)	(482,000)	1,000
GAIN ON DEBT EXTINGUISHMENT	206,000
FOREIGN CURRENCY EXCHANGE LOSS	(7,000)	(13,000)
LOSS BEFORE INCOME TAXES	(4,278,000)	(4,640,000)	(3,725,000)
INCOME TAX EXPENSE	14,000	55,000	8,000
NET LOSS	$ (4,292,000)	$ (4,695,000)	$ (3,733,000)
NET LOSS PER COMMON SHARE - BASIC	$ (0.21)	$ (0.32)	$ (0.26)
NET LOSS PER COMMON SHARE - DILUTED	$ (0.21)	$ (0.32)	$ (0.26)
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - BASIC	20,703	14,741	14,556
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING - DILUTED	20,703	14,741	14,556